Aleta Biotherapeutics Inc.

Calculating rank

USPTO Granted Patents = 8

Forward Citations = 12

Loading Chart...

5 inventors (with patents filed for the assignee):

Paul David Rennert (8 out of 33 patents)

Roy R Lobb (8 out of 29 patents)

Benjamin Joseph Hackel (1 out of 8 patents)

4. John T Schiller (1 out of 34 patents)

5. Justin Klesmith (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 11891426 - CD19 variants (2024-02-06),

2. 11807691 - Compositions and methods for treatment of cancer (2023-11-07),

3. 11207339 - Targeted cancer therapy (2021-12-28),

4. 11059904 - Compositions and methods for tumor transduction (2021-07-13),

5. 10669349 - Compositions and methods for treatment of cancer (2020-06-02),

6. 10508143 - Compositions and methods for treatment of cancer (2019-12-17),

7. 10072094 - Compositions and methods for tumor transduction (2018-09-11),

8. 10066023 - Compositions and methods for tumor transduction (2018-09-04),

Company Overview

Aleta Biotherapeutics Inc. is a biotechnology company focused on developing novel immunotherapies to treat cancer. Our proprietary technology platform enables the engineering of immune cells to enhance their ability to target and destroy cancer cells. We are dedicated to revolutionizing cancer treatment through innovation and cutting-edge science.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#19 in Natick, MA

#2,102 in Massachusetts

#35,954 in US

Natick, MA, United States of America